MedTrace Logo

Defining Disease Activity in Neovascular AMD With Optical Coherence Tomography Angiography

NCT03909425 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 35

Last updated 2023-11-30

No results posted yet for this study

Summary

The purpose of this study is to be able to describe optical coherence angiography (OCTA) patterns of disease activity and quiescence in eyes that have received treatment. The target population group is patients that have neovascular age-related macular degeneration and have had treatment with aflibercept for this condition.

This is a single-site study and does not involve any masking or treatment allocation.

Conditions

  • Neovascular Age-related Macular Degeneration

Sponsors & Collaborators

  • Moorfields Eye Hospital NHS Foundation Trust

    lead OTHER

Principal Investigators

  • Praveen J Patel, FRCOphth, MD · Moorfields Eye Hosptial NHS Foundation Trust

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-02
Primary Completion
2021-08-16
Completion
2021-08-16

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03909425 on ClinicalTrials.gov